Xometry President Sells 6% of Shares in Planned Tax‑Hedge, Raising Governance Questions.

Insider Selling by President Sahni Sanjeev Singh

On January 8 2026, Xometry’s president, Sahni Sanjeev Singh, executed a series of six Rule 10b‑5‑1‑planned sales totaling 21,641 shares. The transactions, all priced between $63.10 and $68.71, were driven by tax‑withholding obligations linked to the vesting of restricted stock units (RSUs). Although the sales were pre‑planned and not a spontaneous divestiture, the sheer volume—approximately 6 % of the company’s outstanding shares—raises questions about the president’s long‑term confidence in Xometry’s prospects.

How the Sale Fits the Company’s Insider Activity Landscape

Xometry’s insider‑trading pattern over the past year has been dominated by high‑frequency sales by its CFO and CEO, with total volumes exceeding 70 k shares in 2025 alone. The president’s recent sale is the first substantial sell order from the top executive since the company’s IPO, and it occurs at a time when the share price is close to its 52‑week high. This juxtaposition—high insider selling amid a bullish price trend—could be interpreted as a signal that senior management is looking to hedge its personal positions rather than a warning of impending trouble.

Implications for Investors

From an equity valuation standpoint, the president’s sale does not alter Xometry’s fundamentals: the company remains loss‑making with a negative price‑to‑earnings ratio of –54.42 and a market cap of $3.5 billion. However, the sale may heighten scrutiny of the company’s governance practices. Investors may view the 10b‑5‑1 plan as a prudent risk‑management tool, but the timing—right after a strong earnings beat and a 2.7 % monthly price gain—could be perceived as a signal of liquidity concerns or a need for cash reserves.

Looking Ahead: What the Insider Deal Means for Xometry’s Future

If Xometry continues to rely on AI‑driven manufacturing solutions and expands its global network, the company’s long‑term growth narrative remains intact. Yet the president’s recent sale, coupled with ongoing insider selling by other executives, underscores the importance of monitoring cash flows and capital allocation. Should the company’s profitability trajectory falter or its valuation be pressured by a broader market correction, the insider sell‑off could accelerate, potentially triggering a self‑fulfilling sell‑pressure cycle. For investors, maintaining a close eye on future Form 4 filings and the company’s cash‑burn rate will be essential to gauge whether this sale is a routine tax‑hedging maneuver or the first of a more pronounced exit strategy.